Advisory Services Network LLC raised its holdings in Thermo Fisher Scientific Inc (NYSE:TMO) by 13.9% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,850 shares of the medical research company’s stock after purchasing an additional 957 shares during the quarter. Advisory Services Network LLC’s holdings in Thermo Fisher Scientific were worth $1,370,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Proficio Capital Partners LLC increased its stake in Thermo Fisher Scientific by 71.5% in the first quarter. Proficio Capital Partners LLC now owns 607 shares of the medical research company’s stock valued at $105,000 after purchasing an additional 253 shares during the period. Chicago Partners Investment Group LLC acquired a new position in Thermo Fisher Scientific in the second quarter valued at $108,000. Cribstone Capital Management LLC increased its stake in Thermo Fisher Scientific by 8.7% in the second quarter. Cribstone Capital Management LLC now owns 625 shares of the medical research company’s stock valued at $109,000 after purchasing an additional 50 shares during the period. Sharkey Howes & Javer increased its stake in Thermo Fisher Scientific by 1.0% in the first quarter. Sharkey Howes & Javer now owns 733 shares of the medical research company’s stock valued at $113,000 after purchasing an additional 7 shares during the period. Finally, Shine Investment Advisory Services Inc. acquired a new position in Thermo Fisher Scientific in the second quarter valued at $113,000. Institutional investors own 83.66% of the company’s stock.

A number of research analysts have recently issued reports on TMO shares. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $215.00 price target on the stock in a research note on Tuesday, October 31st. Leerink Swann reiterated a “buy” rating on shares of Thermo Fisher Scientific in a research note on Monday, October 30th. Deutsche Bank AG set a $226.00 price target on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research note on Thursday, October 26th. Jefferies Group LLC reiterated a “hold” rating and set a $195.00 price target on shares of Thermo Fisher Scientific in a research note on Thursday, September 28th. Finally, Goldman Sachs Group, Inc. (The) started coverage on shares of Thermo Fisher Scientific in a research note on Tuesday, September 26th. They set a “buy” rating and a $225.00 price target on the stock. One research analyst has rated the stock with a hold rating and sixteen have given a buy rating to the company. Thermo Fisher Scientific presently has a consensus rating of “Buy” and an average target price of $205.71.

TRADEMARK VIOLATION WARNING: “Advisory Services Network LLC Acquires 957 Shares of Thermo Fisher Scientific Inc (TMO)” was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another site, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this report can be viewed at https://www.watchlistnews.com/advisory-services-network-llc-acquires-957-shares-of-thermo-fisher-scientific-inc-tmo/1695215.html.

In other Thermo Fisher Scientific news, Director Jim P. Manzi sold 11,318 shares of the company’s stock in a transaction dated Friday, August 18th. The shares were sold at an average price of $172.94, for a total value of $1,957,334.92. Following the sale, the director now owns 38,757 shares of the company’s stock, valued at $6,702,635.58. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Peter E. Hornstra sold 3,894 shares of the company’s stock in a transaction dated Tuesday, September 5th. The shares were sold at an average price of $185.18, for a total transaction of $721,090.92. Following the completion of the sale, the vice president now directly owns 19,751 shares in the company, valued at approximately $3,657,490.18. The disclosure for this sale can be found here. In the last three months, insiders have sold 22,738 shares of company stock worth $4,021,512. 0.49% of the stock is owned by insiders.

Shares of Thermo Fisher Scientific Inc (NYSE:TMO) opened at $186.18 on Friday. The company has a market cap of $76,947.01, a PE ratio of 21.09, a P/E/G ratio of 1.76 and a beta of 1.08. Thermo Fisher Scientific Inc has a fifty-two week low of $139.07 and a fifty-two week high of $201.20. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.85.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 EPS for the quarter, topping analysts’ consensus estimates of $2.24 by $0.07. The firm had revenue of $5.12 billion for the quarter, compared to the consensus estimate of $5.03 billion. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The firm’s revenue was up 13.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.03 earnings per share. analysts forecast that Thermo Fisher Scientific Inc will post 9.36 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Friday, December 15th will be issued a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 0.32%. The ex-dividend date of this dividend is Thursday, December 14th. Thermo Fisher Scientific’s dividend payout ratio is currently 10.19%.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.